Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 27.93 | 18.32 | 25.41 | 11.99 |
Total Revenue | 27.93 | 18.32 | 25.41 | 11.99 |
Costof Revenue Total | 25.41 | 16.09 | 22.58 | 10.61 |
Gross Profit | 2.52 | 2.23 | 2.83 | 1.38 |
Selling/ General/ Admin Expenses Total | 0.22 | 0.29 | 0.28 | 0.12 |
Depreciation/ Amortization | 0.66 | 0.63 | 0.56 | 0.06 |
Other Operating Expenses Total | 0.68 | 0.99 | 1.26 | 0.74 |
Total Operating Expense | 26.98 | 18.00 | 24.68 | 11.53 |
Operating Income | 0.95 | 0.32 | 0.73 | 0.46 |
Interest Inc( Exp) Net- Non- Op Total | -0.14 | -0.15 | -0.37 | -0.09 |
Other Net | 0.18 | 0.85 | 0.58 | 0.46 |
Net Income Before Taxes | 0.98 | 1.03 | 0.94 | 0.83 |
Provisionfor Income Taxes | 0.23 | 0.26 | 0.24 | 0.22 |
Net Income After Taxes | 0.75 | 0.77 | 0.71 | 0.61 |
Net Income Before Extra Items | 0.75 | 0.77 | 0.71 | 0.61 |
Net Income | 0.75 | 0.77 | 0.71 | 0.61 |
Income Availableto Com Excl Extra Ord | 0.75 | 0.77 | 0.71 | 0.61 |
Income Availableto Com Incl Extra Ord | 0.75 | 0.77 | 0.71 | 0.61 |
Diluted Net Income | 0.75 | 0.77 | 0.71 | 0.61 |
Diluted Weighted Average Shares | 1.03 | 0.96 | 0.90 | 0.44 |
Diluted EPS Excluding Extra Ord Items | 0.73 | 0.80 | 0.78 | 1.39 |
Diluted Normalized EPS | 0.73 | 0.80 | 0.78 | 1.39 |
Total Adjustmentsto Net Income | - | 0.00 | - | - |
DPS- Common Stock Primary Issue | - | - | 0.00 | 0.00 |
Eiko Lifesciences Dividend Eiko Lifesciences Bonus Eiko Lifesciences News Eiko Lifesciences AGM Eiko Lifesciences Rights Eiko Lifesciences Splits Eiko Lifesciences Board Meetings Eiko Lifesciences Key Metrics Eiko Lifesciences Shareholdings Eiko Lifesciences Balance Sheet Eiko Lifesciences Cashflow Eiko Lifesciences Q1 Results Eiko Lifesciences Q2 Results Eiko Lifesciences Q3 Results Eiko Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks